28.0% vs. 14.9 Ϯ 23.6%, p Ͻ 0.01) compared with the nonfractured stent group. The absence of stent strut was the common morphological feature of stent fracture in OCT. Both mean and maximal neointimal area were larger in the stent fracture group (fracture 1.59 Ϯ 0.75 mm 2 vs. nonfracture 0.55 Ϯ 0.46 mm 2 , p Ͻ 0.01; and fracture 3.30 Ϯ 1.73 mm 2 vs. nonfracture 1.28 Ϯ 1.10 mm 2 , p Ͻ 0.01, respectively). Although neointima grew equally in the nonfractured stent group, the distribution of neointimal area showed a peak at the fracture site in the fractured stent group (Fig. 2). The longitudinal length of the absence of stent struts was positively correlated with the neointimal area at the fracture site (r ϭ 0.79, p Ͻ 0.01). From the receiver-operating characteristics curve, the best cutoff value of the length of the absence of stent struts to diagnose stent fracture was 1.07 mm (area under the curve 0.85, sensitivity 93%, and specificity 80%).The absence of stent strut was the common morphological feature of stent fracture, and its length was correlated with the neointimal area. These results suggest that the loss of stent strut itself is one of the important contributors to excessive neointimal growth. Previous ex vivo studies reported that cyclic stretch on cultured cells induces the proliferation of vascular smooth muscle cells. We have reported that stent fracture frequently occurs at bend lesions (4). When stent fracture occurs, the stent loses its ability to scaffold the artery wall against mechanical stress. We speculate that occurrence of these mechanical stresses at the fracture site could contribute to excessive neointimal growth. Furthermore, many previous studies have postulated other causes for SES restenosis including stent under-expansion, polymer disruption, stent strut inconsistent distribution, and stent fracture. These factors could directly or indirectly affect the drug delivery. Even though it is difficult to know when the stent was fractured, we speculate that a loss of stent struts at the fracture site may impede effective local drug delivery, resulting in failure to prevent the neointimal growth.